AzTrials
AzTrials

Colorectal CancerNCT05353127

Cardiopulmonary Exercise Test Data Averaging Methods and Preoperative Risk Assessment

An observational study of Colorectal Cancer and Surgery, run by VieCuri Medical Centre at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Cardiopulmonary exercise testing (CPET) is used for preoperative risk assessment in patients with colorectal cancer who need to undergo surgery. For presentation and interpretation purposes, CPET data are averaged by using a time- or breath-based average. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
CPET/Cardiopulmonary Exercise Test
How many people
21 participants
Where
1 siteNetherlands
Study dates
12 Apr 2022to 1 Oct 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: Patients considered for colorectal cancer surgery at the VieCuri Medical Centre Venlo, who had undergone a preoperative CPET before colorectal surgery as a part of a prehabilitation study.

Who may be able to join

  • Patiënts with colorectal cancer, considered for surgery.
  • A score of ≤7 metabolic equivalents of task on the veterans-specific activity questionnaire and therefore performed preoperative CPET as a part of a prehabilitation study

Who cannot join

  • Patiënt unable to perform CPET.

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Viecuri Medical Center

    Venlo, Limburg, 5912BL

Other trials in Netherlands

About this study

Official title: Influence of Different Data Averaging Methods on Preoperative Risk Assessment Using Cardiopulmonary Exercise Testing in Patients Scheduled for Colorectal Surgery

Cardiopulmonary exercise testing (CPET) is used for preoperative risk assessment in patients with colorectal cancer who need to undergo surgery. For presentation and interpretation purposes, CPET data are averaged by using a time- or breath-based average. It is uncertain to what extent differences in data averaging methods influence the numerical value of preoperative CPET-derived variables used for risk assessment. Therefore, the primary aim of this study is to investigate the influence of different CPET data averaging intervals on the numerical values of CPET-derived variables used for preoperative risk assessment in patients scheduled for elective colorectal cancer surgery. The secondary aim is to elucidate the impact of data-averaging intervals on classification of patients into a low- or high-risk category for postoperative complications based on known risk assessment thresholds.

Read the detailed description

Surgery for colorectal cancer is associated with a high incidence of postoperative complications. Risk assessment by means of a cardiopulmonary exercise test (CPET) is an essential part of the preoperative diagnostic work-up of colorectal cancer patients. During CPET, a patient exercises against a progressively increasing work rate until volitional exhaustion, while breath-by-breath respiratory gasses are analyzed. The large number of data points that are collected by the breath-by-breath sampling rate can be a burden for data visualization, as they can be noisy. Therefore, data averaging is performed to optimize graphical data display and to aid CPET interpretation. To date, there are no studies quantifying the extent to which differences in data averaging influence the numerical value of preoperative CPET-derived variables for risk assessment based on aerobic fitness, such as the the oxygen uptake (VO2) at the ventilatory anaerobic threshold (VAT), VO2 at peak exercise (VO2peak), and the oxygen uptake efficiency slope (OUES), and of preoperative CPET-derived variables for risk assessment based on ventilatory efficiency, such as the ventilatory equivalent for carbon dioxide production at the VAT (VE/VCO2VAT) and the slope of the relationship between the minute ventilation and carbon dioxide production (VE/VCO2-slope). Therefore, the primary aim of this study is to investigate the influence of different CPET data averaging intervals on the numerical values of CPET-derived variables used for preoperative risk assessment in patients scheduled for elective colorectal cancer surgery. The secondary aim is to elucidate the impact of data-averaging intervals on the classification of patients into a low- or high-risk category for postoperative complications based on known risk assessment thresholds.

Participants Data from patients considered for colorectal cancer surgery who are ≥18 years of age, have a score ≤7 metabolic equivalents of task on the veterans-specific activity questionnaire, and therefore performed preoperative CPET as a part of a prehabilitation study will be collected. Preoperative CPET was conducted before any intervention was initiated.

Procedures Preoperative CPET data will be anonymized and patient characteristics other than anthropometric measures will be concealed. A medical physiologist and a clinical exercise physiologist will determine the CPET variables VO2VAT, VO2peak, respiratory exchange ratio at peak exercise (RERpeak), VE/VCO2VAT, VE/VCO2-slope, and the OUES in all 20 CPETs using a predefined set of guidelines Final determination of each parameter will be based on consensus between the two observers. In case of disagreement between observers, a third observer will be consulted. Determination of the aforementioned CPET variables will be repeated using each of the five different data-averaging intervals. Data averaging-intervals consists of a stationary time-based average over 10, 20, and 30 seconds, and of a rolling average over 3 and 7 breaths that were defined as follows. The stationary time-based average will be calculated by averaging the breath-by-breath data over 10, 20, or 30 seconds. A rolling average is defined as averaging a fixed number of single breath measurements (i.e., 3 and 7), then discarding the first breath and adding a new breath to obtain a new breath averaging block.

CPET interpretation will be performed using Blue Cherry software version 1.3.3.3 (Geratherm Respiratory GmbH, Bad Kissingen, Germany).

Apart from the CPET data, the preoperative patient characteristics age, sex, body mass index, smoking status (never, former, current), age-adjusted Charlson comorbidity index, comorbidities, American Society of Anesthesiologists classification, veterans-specific activity questionnaire score, hemoglobin levels (mmol/L), and tumor location will be recorded.

To assess the influence of different CPET data averaging intervals on the numerical values of CPET-derived variables, mean differences of the numerical values of VO2VAT, VO2peak, RERpeak, VE/VCO2VAT, VE/VCO2-slope, and OUES between different data-averaging intervals will be analyzed by means of within factors repeated measures analysis of variance (ANOVA). In case of a statistically significant difference between methods (p<0.05), post-hoc testing will be performed using the Bonferroni test to identify the exact differences. To evaluate the influence of data-averaging intervals on risk assessment, participants will be classified as being at low or high risk for postoperative complications based on their VO2VAT, VO2peak, VE/VCO2VAT, and OUES. For each CPET-derived variable, numerical values will be determined for each of the five data-averaging will be compared with known preoperative risk assessment thresholds (patients will be classified as high-risk when having a VO2VAT <11.1 mL/kg/min, a VO2peak <18.2 mL/kg/min, a VE/VCO2VAT >30.9, and/or an OUES/kg <20.6). Friedman's test will be used to determine whether differences in risk assessment exist between data-averaging methods. Differences between data-averaging methods will be assumed statistically significant when p<0.05.

Being tested
CPET/Cardiopulmonary Exercise Test
Keywords
colorectal surgery, Prehabilitation, CPET, CardioPulmonary Exercise Testing
Medical subject headings
Colorectal Neoplasms, Colonic Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CPET/Cardiopulmonary Exercise TestDiagnostic test

    During CPET, a patient exercises against a progressively increasing work rate until volitional exhaustion, while breath-by-breath respiratory gasses are analyzed.

Study groups in NCT05353127
Study groupRoleWhat they receive
Patiënts who underwent a CPET prior to elective colorectal surgery investigate fitness level.Patients considered for colorectal cancer surgery who were ≥18 years of age, had a score ≤7 metabolic equivalents of task on the veterans-specific activity questionnaire.
Receives: Diagnostic Test: CPET/Cardiopulmonary Exercise Test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Influence of different CPET data averaging intervals on the numerical values of CPET-derived variables.

    To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VO2VAT,

    Measured: Baseline, pre surgery

  2. Influence of different CPET data averaging intervals on the numerical values of CPET-

    To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VO2peak.

    Measured: Baseline, pre surgery

  3. Influence of different CPET data averaging intervals on the numerical values of CPET-

    To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VE/VCO2-slope.

    Measured: Baseline, pre surgery

  4. Influence of different CPET data averaging intervals on the numerical values of CPET-

    To assess the influence of different CPET data averaging intervals on the numerical the numerical values of RERpeak.

    Measured: Baseline, pre surgery

  5. Influence of different CPET data averaging intervals on the numerical values of CPET-

    To assess the influence of different CPET data averaging intervals on the numerical the numerical values of VE/VCO2VAT.

    Measured: Baseline, pre surgery

  6. Influence of different CPET data averaging intervals on the numerical values of CPET-

    To assess the influence of different CPET data averaging intervals on the numerical the numerical values of the OUES.

    Measured: Baseline, pre surgery

Secondary outcomes (1)
  1. High- or Low-risk for postoperative complications

    Patients are classified as high-risk when having a VO2VAT <11.1 mL/kg/min, a VO2peak <18.2 mL/kg/min, a VE/VCO2VAT >30.9 [12], and/or an OUES/kg <20.6

    Measured: Baseline, pre surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2022
  2. Study start12 Apr 2022
  3. Primary completion1 Sep 2022
  4. Study completion1 Oct 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05353127
Sponsor's protocol ID
2022_053
Status last verified
Apr 2022
First submitted
8 Apr 2022
Last updated
23 Nov 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Franssen RFW, Sanders BHE, Takken T, Vogelaar FJ, Janssen-Heijnen MLG, Bongers BC. Influence of different data-averaging methods on mean values of selected variables derived from preoperative cardiopulmonary exercise testing in patients scheduled for colorectal surgery. PLoS One. 2023 Mar 16;18(3):e0283129. doi: 10.1371/journal.pone.0283129. eCollection 2023.

    PubMed 36928094

Questions about this trial

What is this clinical trial studying?

An observational study of Colorectal Cancer and Surgery, run by VieCuri Medical Centre at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Influence of different CPET data averaging intervals on the numerical values of CPET-derived variables. (time frame: Baseline, pre surgery). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05353127, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Nov 2022; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in